nach oben

Erschienen in:

01.10.2022 | News item

COMIRNATY and COMIRNATY Bivalent have same colour vial cap

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Heath Canada authorised Pfizer-BioNTech's new COVID-19 vaccine, COMIRNATY Bivalent, as a booster vaccine on 7 October 2022, but is warning healthcare professionals that it currently has the same grey-coloured vial cap as original monovalent COMIRNATY 30 mcg/0.3 mL, so careful attention must be paid to the vial label and carton label in order to avoid medication errors. COMIRNATY bivalent and monovalent vaccines with grey caps and label borders do not require dilution. …

COMIRNATY Original & Omicron BA.4/BA.5 Bivalent Vaccine with English-only Vial and Carton Labels Internet Document : 11 Oct 2022. Available from: URL: https://recalls-rappels.canada.ca/en/alert-recall/comirnaty-original-omicron-ba4ba5-bivalent-vaccine-english-only-vial-and-carton-labels

Titel: COMIRNATY and COMIRNATY Bivalent have same colour vial cap
Publikationsdatum: 01.10.2022
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-25266-x

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

COMIRNATY and COMIRNATY Bivalent have same colour vial cap

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Prednisone/tacrolimus

Azathioprine/ciclosporin/prednisolone

Aripiprazole/pregabalin/procyclidine

Antipsychotics drugs

Minimising brolucizumab-related retinal vasculitis, retinal vein occlusion

Antivirals